Tofacitinib: Uses, Dosage, Side Effects, Warnings - Drugs.com
2023年8月23日 · Tofacitinib is a janus kinase (JAK) inhibitor and disease modifying anti-rheumatic drug (DMARD). It works by suppressing the immune system and is used to treat certain inflammatory conditions.
Tofacitinib - Wikipedia
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis.
Tofacitinib (oral route) - Mayo Clinic
Tofacitinib is used alone or together with other medicines (eg, DMARDs) to treat moderate to severely active rheumatoid arthritis, active psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, and polyarticular course juvenile idiopathic arthritis (pcJIA) in patients who have taken other medicines (eg, methotrexate) that did not work ...
Tofacitinib: MedlinePlus Drug Information
Tofacitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who are unable to take or did not respond to one or more tumor necrosis factor (TNF) inhibitor medication (s).
Tofacitinib - StatPearls - NCBI Bookshelf
2023年7月3日 · Tofacitinib is a Janus kinase (JAK) inhibitor FDA-approved in April 2012 indicated for its use in the management of rheumatoid arthritis (RA), psoriatic arthritis (PA), ulcerative colitis (UC), and polyarticular course juvenile idiopathic arthritis (pcJIA).
Tofacitinib: Uses, Interactions, Mechanism of Action - DrugBank …
Tofacitinib is a Janus kinase (JAK) inhibitor used to treat rheumatic conditions, such as rheumatoid arthritis and ankylosing spondylitis, and ulcerative colitis.
Xeljanz (tofacitinib) - Uses, Side Effects, and More - WebMD
2024年7月1日 · What is Xeljanz used for? Xeljanz (tofacitinib) is commonly used for the following conditions. Learn more about managing rheumatoid arthritis with Xeljanz. Learn more about Xeljanz for ulcerative...
Xeljanz (Tofacitinib): Uses & Side Effects - Cleveland Clinic
TOFACITINIB (TOE fa SYE ti nib) treats rheumatoid arthritis, psoriatic arthritis, and polyarticular juvenile idiopathic arthritis. It is also used to treat ankylosing spondylitis and ulcerative colitis.
Tofacitinib: Side Effects, Uses, Dosage, Interactions, Warnings
Tofacitinib is a prescription medication used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis, and Ankylosing Spondylitis. Tofacitinib is available under the following different brand names: Xeljanz, Xeljanz XR.
Xeljanz: Uses, Side Effects, Warnings - Drugs.com
2024年8月22日 · Xeljanz (tofacitinib) is a biologic medicine classified as Janus kinus (JAK) inhibitor and is used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis in adults and for polyarticular juvenile idiopathic arthritis in patients 2 years and older.